Jin Peng

774 total citations
23 papers, 448 citations indexed

About

Jin Peng is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Jin Peng has authored 23 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Jin Peng's work include Cancer, Hypoxia, and Metabolism (5 papers), MicroRNA in disease regulation (4 papers) and DNA Repair Mechanisms (3 papers). Jin Peng is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), MicroRNA in disease regulation (4 papers) and DNA Repair Mechanisms (3 papers). Jin Peng collaborates with scholars based in China, United States and Australia. Jin Peng's co-authors include M. Nakamoto, William T. O'Donnell, Stephen T. Warren, Christine Teal, Rachel F. Brem, Sidney W. Fu, Shejuan An, Xiaohui Tan, Katayoon Rezaei and Sana Tabbara and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Human Molecular Genetics.

In The Last Decade

Jin Peng

21 papers receiving 442 citations

Peers

Jin Peng
Shashank Sathe United States
Mengqi Chang China
Wenqi Xu China
Yi-Feng Xu China
Masaki Hosogane Japan
Tom Feys Belgium
Jingwen Wu China
Natalya Benderska Germany
Haibo Xu China
Shilei Liu China
Shashank Sathe United States
Jin Peng
Citations per year, relative to Jin Peng Jin Peng (= 1×) peers Shashank Sathe

Countries citing papers authored by Jin Peng

Since Specialization
Citations

This map shows the geographic impact of Jin Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Peng more than expected).

Fields of papers citing papers by Jin Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Peng. The network helps show where Jin Peng may publish in the future.

Co-authorship network of co-authors of Jin Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Jin Peng. A scholar is included among the top collaborators of Jin Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin Peng. Jin Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Lin, Ji Li, Jin Peng, et al.. (2025). Loss of ADAR1 in lung cancer activates anti-tumour immunity and suppresses tumour cell growth via the RIG-I/MDA5-MAVS pathway. Cancer Letters. 635. 218071–218071. 1 indexed citations
2.
3.
Liu, Xin, Jin Peng, Changlong Wei, et al.. (2024). An evaluation approach integrating remedial duration for sustainable mega-site remediation in China. Pedosphere. 35(6). 1026–1038. 1 indexed citations
4.
Zhang, Li‐Kang, et al.. (2024). Ganodermanontriol regulates tumor-associated M2 macrophage polarization in gastric cancer. Aging. 16(2). 1390–1398. 4 indexed citations
5.
Su, Ke, Binghua Li, Ye Wang, et al.. (2023). Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study. BMC Cancer. 23(1). 1081–1081. 4 indexed citations
6.
Jiang, Xiang, Jin Peng, Yuanyuan Xie, et al.. (2023). Oxoglutarate dehydrogenase-like inhibits the progression of hepatocellular carcinoma by inducing DNA damage through non-canonical function. Cell Death and Differentiation. 30(8). 1931–1942. 6 indexed citations
7.
Peng, Jin, et al.. (2022). Peripheral Circular RNA Profiling from Patients with Allergic Rhinitis Identified hsa_circRNA_404013 as a Potential Diagnostic Biomarker. International Archives of Allergy and Immunology. 183(10). 1078–1088. 6 indexed citations
8.
Jin, Chengjuan, Shuai Feng, Yang Zhang, et al.. (2022). Effects of Neoadjuvant Chemotherapy in Ovarian Cancer Patients With Different Germline BRCA1/2 Mutational Status: A Retrospective Cohort Study. Frontiers in Oncology. 11. 810099–810099. 2 indexed citations
9.
Li, Junjun, Jin Peng, Qunli Xiong, et al.. (2022). Cdh1 Deficiency Sensitizes TNBC Cells to PARP Inhibitors. Genes. 13(5). 803–803. 4 indexed citations
10.
Wang, Jiewei, Yiping Dong, Lingzhi Wu, et al.. (2021). The deubiquitinase USP28 stabilizes the expression of RecQ family helicases and maintains the viability of triple negative breast cancer cells. Journal of Biological Chemistry. 298(1). 101443–101443. 9 indexed citations
11.
Zheng, Fangchao, Feng Du, Jiuda Zhao, et al.. (2021). The emerging role of RNA N6-methyladenosine methylation in breast cancer. Biomarker Research. 9(1). 39–39. 29 indexed citations
12.
Qian, Liyuan, Yunzheng Li, Yajuan Cao, et al.. (2021). Pan-Cancer Analysis of Glycolytic and Ketone Bodies Metabolic Genes: Implications for Response to Ketogenic Dietary Therapy. Frontiers in Oncology. 11. 689068–689068. 9 indexed citations
13.
14.
Chen, Lulu, Jin Peng, You Wang, et al.. (2020). Fenofibrate-induced mitochondrial dysfunction and metabolic reprogramming reversal: the anti-tumor effects in gastric carcinoma cells mediated by the PPAR pathway.. PubMed. 12(2). 428–446. 31 indexed citations
15.
Peng, Jin, Lichun Tang, Mengjiao Cai, et al.. (2019). RECQL5 plays an essential role in maintaining genome stability and viability of triple‐negative breast cancer cells. Cancer Medicine. 8(10). 4743–4752. 16 indexed citations
16.
Xiong, Lili, et al.. (2019). Exosomes from Bone Marrow Mesenchymal Stem Cells Can Alleviate Early Brain Injury After Subarachnoid Hemorrhage Through miRNA129-5p-HMGB1 Pathway. Stem Cells and Development. 29(4). 212–221. 58 indexed citations
17.
Plieskatt, Jordan, Gabriel Rinaldi, Yanjun Feng, et al.. (2015). A microRNA profile associated with Opisthorchis viverrini-induced cholangiocarcinoma in tissue and plasma. BMC Cancer. 15(1). 309–309. 34 indexed citations
18.
Peng, Jin, Yanjun Feng, Gabriel Rinaldi, et al.. (2014). Profiling miRNAs in nasopharyngeal carcinoma FFPE tissue by microarray and Next Generation Sequencing. Genomics Data. 2. 285–289. 11 indexed citations
19.
Tan, Xiaohui, Jin Peng, Yebo Fu, et al.. (2014). miR-638 mediated regulation of BRCA1affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer. Breast Cancer Research. 16(5). 435–435. 105 indexed citations
20.
Nakamoto, M., Jin Peng, William T. O'Donnell, & Stephen T. Warren. (2005). Physiological identification of human transcripts translationally regulated by a specific microRNA. Human Molecular Genetics. 14(24). 3813–3821. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shashank Sathe Breakdown of academic impact, for papers by Mengqi Chang Breakdown of academic impact, for papers by Wenqi Xu Breakdown of academic impact, for papers by Yi-Feng Xu Breakdown of academic impact, for papers by Masaki Hosogane Breakdown of academic impact, for papers by Tom Feys Breakdown of academic impact, for papers by Jingwen Wu Breakdown of academic impact, for papers by Natalya Benderska Breakdown of academic impact, for papers by Haibo Xu Breakdown of academic impact, for papers by Shilei Liu
Rankless by CCL
2026